Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Profound Medical Corp.

< Previous 1 2 Next >
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Non-Brokered Private Placement
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Proposed Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Third Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Second Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Upcoming Investor Events
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Annual and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces First Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Present at the 43rd Annual Cowen Health Care Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Present at the 2022 Jefferies London Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.